Ipca Laboratories Ltd Share Price – NSE  / BSE

Pharmaceuticals, Small Cap

Ipca Laboratories has received necessary approval for voluntary closure of its wholly owned subsidiary Ipca Pharmaceuticals SA de CV, Mexico.

This wholly owned subsidiary incorporated in Mexico was not doing any business for the past several years. Voluntary closure of this wholly owned subsidiary will not have any impact on Company's business or financials.

Powered by Capital Market - Live News

Ipca Laboratories Ltd gained for a third straight session today. The stock is quoting at Rs 1591.25, up 1.57% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 1.25% on the day, quoting at 23745.85. The Sensex is at 78340.19, up 1.29%. Ipca Laboratories Ltd has slipped around 1.43% in last one month.

Meanwhile, Nifty Pharma index of which Ipca Laboratories Ltd is a constituent, has slipped around 5.27% in last one month and is currently quoting at 21544.15, up 1.67% on the day. The volume in the stock stood at 2.47 lakh shares today, compared to the daily average of 3.37 lakh shares in last one month.

The benchmark November futures contract for the stock is quoting at Rs 1593.75, up 1.8% on the day. Ipca Laboratories Ltd is up 50.01% in last one year as compared to a 20.57% spurt in NIFTY and a 38.57% spurt in the Nifty Pharma index.

The PE of the stock is 56.98 based on TTM earnings ending September 24.

Powered by Capital Market - Live News

Ipca Laboratories has fixed 27 November 2024 as record date for interim dividend for FY 2024-25.

Powered by Capital Market - Live News

Ipca Laboratories announced that the Board of Directors of the Company at its meeting held on 14 November 2024, has recommended a Interim dividend of Rs.2 per share (i.e.200%), subject to the approval of the shareholders.

Powered by Capital Market - Live News